Acadia Pharmaceuticals ACAD Income Statements

Conto economico

Quarter End	Dic 2022	Mar 2023	Giu 2023	Set 2023	Dic 2023	Mar 2024	Giu 2024	Set 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Entrate totali	136,49M	118,46M	165,24M	211,7M	231,04M	205,83M	241,96M	250,4M
Reddito operativo	-46,06M	-53,58M	3,04M	-57,78M	34,94M	15,21M	30,44M	31,64M
Reddito ante imposte	-40,89M	-44,94M	6,34M	-52,14M	39,7M	21M	37,18M	38,81M
Reddito netto	-41,73M	-43,02M	1,11M	-65,18M	45,8M	16,56M	33,39M	32,77M
Dividendi preferiti	0	0	0	0	0	0	0	0
Utile base per azione (EPS)	0	0	0	0	0	0	0	0
UTILE OPERATIVO	-46,06M	-53,58M	3,04M	-52,67M	34,94M	15,5M	30,82M	32,22M
EBITDA	-45,57M	-53,16M	4,8M	-56,05M	36,58M	20,74M	33,01M	34,21M

Fine anno 31 Dicembre 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Entrate totali	17,33M	124,9M	223,81M	339,08M	441,76M	484,15M	517,24M	726,44M
Reddito operativo	-272,82M	-292,41M	-247,44M	-246,55M	-286,59M	-170,44M	-223,6M	-73,38M
Reddito ante imposte	-270,05M	-288,28M	-243,94M	-234,38M	-280,97M	-167,52M	-213,44M	-51,04M
Reddito netto	-271,39M	-289,4M	-245,19M	-235,26M	-281,58M	-167,87M	-215,98M	-61,29M
Dividendi preferiti	0	0	0	0	0	0	0	0
Utile base per azione (EPS)	-2.236	-2.326	-1.704	-1.515	-1.764	-1.043	-1.333	-0.373
UTILE OPERATIVO	-272,82M	-292,41M	-247,44M	-246,55M	-286,59M	-170,44M	-223,6M	-73,38M
EBITDA	-270,99M	-289,7M	-244,44M	-243,78M	-283,65M	-167,1M	-221,57M	-67,83M